Vertex Pharma (VRTX) Posts Q3 Loss of 32c/Share; Will Cut Workforce, Refocus on CF
Tweet Send to a Friend
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q3 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
